Berlin, June 3, 2022, – Bayer will current new renal and cardiovascular details from the detailed Kerendia™ (finerenone) clinical trial method at the 2022 American Diabetic issues Affiliation (ADA) 82nd Scientific Periods. This new knowledge will comprise of even further insights from FIDELITY, which includes late-breaking data from a new put up-hoc examination…
Read More
